Pituitary

Article	Citations
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study	85
Predictors of biochemical remission after transsphenoidal surgery in a large cohort of acromegaly patients	68
Substance P and Neurokinin-1 receptor are overexpressed in adamantinomatous craniopharyngioma than in the pituitary gland	42
A comparison of macular ganglion cell and retinal nerve fibre layer optical coherence tomographic parameters as predictors of visual outcomes of surgery for pituitary tumours	38
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas	36
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency	36
The impact of facility type and volume on treatment and overall survival in craniopharyngioma	32
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours	31
Prevalence and risk factors of colon polyps and other colonic lesions in acromegaly: Insights from colonoscopy screening	29
Treatment and prognostic factors of pituicytoma: a single-center experience and comprehensive literature review	27
Pituitary: hic manebimus optime	24
Functioning gonadotroph adenomas in premenopausal women: clinical and molecular characterization and review of the literature	24
Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging‑derived texture features	24
Sleep disruption in patients with active and treated endogenous Cushing’s syndrome	23
Acromegaly increases depressive symptoms and reduces quality of life of cohabitants	23
Machine learning as a clinical decision support tool for patients with acromegaly	22
Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery	22
Radiological evolution of autograft fat used for skull base reconstruction after transsphenoidal surgery for pituitary adenomas	22
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience	21
Basal cortisol in relation to metyrapone confirmation in predicting adrenal insufficiency after pituitary surgery	21
Pituitary metastases: a case series and scoping review	21
Gigantism: microsurgical treatment by transsphenoidal approach and prognostic factors	21
Hospital frailty risk score predicts postoperative outcomes after endoscopic endonasal resection of non-functioning pituitary adenomas	19
Pituitary surgery in Cushing’s disease: first line treatment and role of reoperation	18
The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions	18

Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre	18
The assessment of thiol-disulfide homeostasis and ıschemia-modified albumin levels in patients with acromegaly	18
Genetic models of Cushing’s disease	18
A post-hoc internal validation of arginine-stimulated copeptin cut-offs for diagnosing AVP deficiency (central diabetes insipidus)	18
Medical management pathways for Cushing’s disease in pituitary tumors centers of excellence (PTCOEs)	17
Pituitary metastases from neuroendocrine neoplasms: case report and narrative review	17
Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes	17
Normative data for pituitary size and volume in the general population between 50 and 66 years	17
Shared decision-making and detection of comorbidities in an online acromegaly consultation with and without the Acromegaly Disease Activity Tool ACRODAT® using the simulated person approach	16
Psychiatric morbidity in acromegaly: a cohort study and meta-analysis of the literature	16
Correction: Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders	16
TSH-secreting pituitary adenomas and bone	15
IGF-1 is positively associated with BMI in patients with acromegaly	15
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors	15
Reappraising prediction of surgical complexity of non-functioning pituitary adenomas after transsphenoidal surgery: the modified TRANSSPHER grade	14
How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)	14
Response to letter to the editor “Hypopituitarism and COVID-19, what else?”	14
Cushing’s disease and bone	14
Outcomes in surgical management of microprolactinomas: an international multi-institutional series	14
Generating novel pituitary datasets from open-source imaging data and deep volumetric segmentation	14
Clinical, surgical, and endocrine outcome following treatment of posterior pituitary tumors: a retrospective cohort study	13
Pituitary surgery and COVID	13
Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome	13
Copeptin after pituitary surgery: is it worth measuring?	13
Acromegaly is associated with a distinct oral and gut microbiota	13
Prevalence of Nelson’s syndrome after bilateral adrenalectomy in patients with cushing’s disease: a systematic review and meta-analysis	13
Clinical and prognostic implications of pituitary macroadenomas (PitNets) grading: a monocentric experience	12
[68 Ga]-DOTATATE PET/MR-based evaluation of physiologic somatostatin receptor 2 expression in the adult pituitary gland as a function of age and sex in a prospective cohort	12
Is diabetes with acromegaly for life?	12
Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomas	12
Long COVID and pituitary dysfunctions: a bidirectional relationship?	11
Mental health disorders in newly diagnosed non-functional pitutary adenoma under initial observation: an observational cohort study using the nationwide MarketScan database	11
Refractory nonfunctioning pituitary adenomas	11
Usefulness of a clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese	11
Serum biomarkers of colonic polyps in patients with acromegaly: a meta-analysis and systematic review	11
The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults	11
Headache in patients with non-functioning pituitary adenoma before and after transsphenoidal surgery – a prospective study	11
Characterization of a paradoxical post-operative increase in serum cortisol in Cushing disease	11
Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis	11
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis	11
Hypopituitarism and pregnancy: clinical characteristics, management and pregnancy outcome	11
Demonstration of the inferior intercavernous sinus is closely linked to the extent of pneumatization of the sphenoid sinus: useful information for the pituitary surgeon	10
Surgical treatment of cystic pituitary adenomas: literature-based definitions and postoperative outcomes	10
Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans	10
Diffusion-weighted imaging does not seem to be a predictor of consistency in pituitary adenomas	10
Proportion and predictors of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists	10
Measuring pituitary tumor volume: a comparison of the simplified and non-simplified ellipsoid equation with the 3D planimetric volume assessment	10
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States	10
Skeletal fragility in pituitary disease: how can we predict fracture risk?	10
Low prevalence of neuropathic-like pain symptoms in long-term controlled acromegaly	10

Importance of 24 h ambulatory blood pressure monitoring in patients with acromegaly and correlation with cardiac magnetic resonance findings	10
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma	10
Cushing’s disease: role of preoperative and primary medical therapy	10
Posterior hypothalamic involvement on pre-operative MRI predicts hypothalamic obesity in craniopharyngiomas	9
Can we predict the risk of venous thromboembolism in patients with Cushing’s syndrome: a nationwide cohort analysis	9
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours	9
Correction: consensus on criteria for acromegaly diagnosis and remission	9
An update on, and genetics of refractory adenomas of childhood	9
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma	9
The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency	9
Changes in pituitary adenoma patient presentation and outcomes during the COVID pandemic at a Pituitary Center of Excellence	9
Acute elevation of interleukin 6 and matrix metalloproteinase 9 during the onset of pituitary apoplexy in Cushing’s disease	9
HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency	9
Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease	8
Clinical use of [18F]fluoro-ethyl-L-tyrosine PET co-registered with MRI for localizing prolactinoma remnants	8
How to manage intolerance to dopamine agonist in patients with prolactinoma	8
Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in Japan	8
The comprehensive evaluation of oral and fecal microbiota in patients with acromegaly	8
Syndrome of inappropriate antidiuresis/hyponatremia in COVID-19	8
Impact of intraoperative magnetic resonance imaging on gross total resection, extent of resection, and residual tumor volume in pituitary surgery: systematic review and meta-analysis	8
Glucose metabolism, gut-brain hormones, and acromegaly treatment: an explorative single centre descriptive analysis	8
Giant prolactinomas, a detailed analysis of 196 adult cases	8
Correction: Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study	8
Elevated risk of recurrence and retreatment for silent pituitary adenomas	7
Pituitary enlargement in patients with cerebrospinal fluid drainage due to ventricular shunt insertion: know the condition and do not mistake for adenoma	7
Pituitary apoplexy: a comprehensive analysis of 93 cases across functioning and non-functioning pituitary adenomas from a single-center	7
Pituitary acting drugs: cabergoline and pasireotide	7
Sellar and perisellar meningiomas: effects on pituitary function in a Spanish cohort observational study	7
Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center	7
Clinico-radiological correlation of pituitary stalk interruption syndrome in children with growth hormone deficiency	7
Cushing’s syndrome and COVID-19	7
Pituitary Tumor Centers of Excellence (PTCOE) should now include neuro-oncologic input	7
Reported baseline variables in transsphenoidal surgery for pituitary adenoma over a 30 year period: a systematic review	7
Identification of mutant K-RAS in pituitary macroadenoma	7
Growth hormone alters gross anatomy and morphology of the small and large intestines in age- and sex-dependent manners	7
Metastases to the pituitary gland: insights from the German pituitary tumor registry	7
Serum copeptin levels at day two after pituitary surgery and ratio to baseline predict postoperative central diabetes insipidus	7
Impulse control disorders in patients with pituitary adenoma managed with or without dopamine agonists: a cross-sectional study from a UK centre	7
Selective resection of the medial wall of the cavernous sinus in pituitary surgery: results of a prospective single center analysis	7
Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors—a review of research and clinical practice	6
Surgical outcomes of medically failed prolactinomas: a systematic review and meta-analysis	6
Exploring the role of the tumor microenvironment in refractory pituitary tumor pathogenesis	6
Role of Radiation in the treatment of Cushing Disease	6
Cushing’s disease in children: unique features and update on genetics	6
Responsiveness to DDAVP in Cushing’s disease is associated with USP8 mutations through enhancing AVPR1B promoter activity	6
GHR disruption in mature adult mice alters xenobiotic metabolism gene expression in the liver	6
The role of endoscopic endonasal surgery in the management of prolactinomas based on their invasiveness into the cavernous sinus	6
Letter to the editor regarding “Vascular anomalies in patients with growth hormone-secreting pituitary adenomas: illustrative case report and systematic review of the literature”	6
Vitamin D in pituitary driven osteopathies	6
Novel imaging techniques in refractory pituitary adenomas	6
Refractory Pit1 plurihormonal tumours and thyrotroph adenomas	5
Cushing’s disease: adrenal steroidogenesis inhibitors	5
The role of the dentist and orthodontist in recognizing oro-facial manifestations of acromegaly: a questionnaire-based study	5
Sheehan syndrome: a current approach to a dormant disease	5
Hypopituitarism and COVID-19	5
Reported outcomes in transsphenoidal surgery for pituitary adenomas: a systematic review	5
Preoperative differentiation of hypophysitis and pituitary adenomas using a novel clinicoradiologic scoring system	5
The role of stereotactic radiosurgery in the multidisciplinary management of pituitary metastases	5
High prevalence of overweight/obesity and dyslipidemia in patients with intracranial germ cell tumors	5
Correction: Giant prolactinomas, a detailed analysis of 196 adult cases	5
A patient-reported outcome measure for patients with pituitary adenoma undergoing transsphenoidal surgery	5
Recovery from hypogonadism in men with prolactinoma treated with dopamine agonists	5
An Infundibular Unidentified Object (IUO): a new pituitary stalk marker?	5
Changing the name of diabetes insipidus	5
Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay	5
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience	5
11C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy	5
Exploring sex-specific hematological changes and their impact on quality of life in patients with prolactinoma	5
Impact of etiology, sex, diabetes mellitus and remission status on erythrocytic profile in patients with cushing’s syndrome: a large population database study	5
The efficacy of a visiting surgical service versus that of a hospital-based surgical service in providing endoscopic endonasal surgery to remove nonfunctioning pituitary adenomas in rural communities	5
Treatment of non-functioning pituitary adenoma with cabergoline: a systematic review and meta-analysis	5
Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results	4
Differences between immunotherapy-induced and primary hypophysitis—a multicenter retrospective study	4
Opioids and pituitary function: expert opinion	4
Dabrafenib as a diagnostic and therapeutic strategy for the non-surgical management of papillary craniopharyngioma	4
FGFR1 variation in the divergent settings of congenital hypopituitarism and pituitary tumours	4
Impact of patient-reported nasal symptoms on quality of life after endoscopic pituitary surgery: a prospective cohort study	4
Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?	4
Precocious puberty, pandemic and beyond	4
Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers	4

Sleep quality in patients with non-functioning pituitary adenoma: impact of replacement therapies with an emphasis on the time of hydrocortisone	4
Clinicopathological analysis of non-functioning pituitary adenomas (PAs) according to the 2022 WHO classification	4
Treatment of recurrent and persistent Cushing’s disease after first transsphenoidal surgery: lessons learned from an international meta-analysis	4
A prospective study on the efficacy of oral estrogen in female patients with acromegaly	4
Somapacitan-induced reversible lipoatrophy in an adult woman with hypopituitarism	4
Clinical and imaging findings for the evaluation of large Rathke’s cleft cysts and cystic craniopharyngiomas	4
Giant prolactinoma in children and adolescents: a single-center experience and systematic review	4
Epigenetic implications in the pathogenesis of corticotroph tumors	4
Newer parameters of the octreotide test in patients with acromegaly	3
The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study	3
Diagnostic, therapeutic, and prognostic characteristics of patients with acromegaly according to tumor size at diagnosis	3
Advances in surgical approaches for refractory pituitary adenomas	3
A procedure in mice to obtain intact pituitary-infundibulum-hypothalamus preparations: a method to evaluate the reconstruction of hypothalamohypophyseal system	3
Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders	3
Levoketoconazole in the treatment of patients with endogenous Cushing’s syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS)	3
Impact of insurance on outcomes of patients undergoing endoscopic transsphenoidal surgery for non-functional pituitary adenomas: a single institution study	3
Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI	3
Pituitary and COVID-19 vaccination: a systematic review	3
Glucose intolerance in acromegaly is driven by low insulin secretion; results from an intravenous glucose tolerance test	3
Clinical characteristics and therapeutic outcomes of acromegalic patients with giant growth hormone-secreting pituitary adenomas: a single-center study of 67 cases	3
Role of biological effective dose for prediction of endocrine remission in acromegaly patients treated with stereotactic radiosurgery	3
Good response rates and predictors during the first year of cabergoline treatment in large invasive prolactinomas	3
Current status of artificial intelligence technologies in pituitary adenoma surgery: a scoping review	3
Differential diagnosis between Cushing’s syndrome and non-neoplastic hypercortisolism: are we getting there?	3
Surgical strategies in the treatment of MR-negative Cushing’s Disease: a systematic review and treatment algorithm	3
Contemporary radiotherapy and radiosurgery techniques for refractory pituitary adenomas	3
Efficacy and safety of pasireotide treatment in acromegaly: A systematic review and single arm meta-analysis	3
Late Night Salivary Cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing’s syndrome)	3
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)	3
Temporal and masseter muscle evaluation by MRI provides information on muscle mass and quality in acromegaly patients	3
Pituitary hypophysitis in granulomatosis with polyangiitis (GPA): a case series	3
Correlates of prolonged length of stay after endoscopic transsphenoidal surgery for pituitary adenomas: varying definitions and non-clinical factors	3
Repeat endoscopic endonasal transsphenoidal surgery for residual or recurrent Cushing’s disease: safety, feasibility, and success	3
“Intrasellar tumor-to-tumor metastasis: A single center experience with a systematic review”	3
Evaluation of acromegaly treatment direct costs with respect to biochemical control and follow-up length	3
Anterior-posterior diameter is a key driver of resectability and complications for pituitary adenomas with suprasellar extension in endoscopic transsphenoidal surgery	3
Post-operative surveillance for somatotroph, lactotroph and non-functional pituitary adenomas after curative resection: a systematic review	3